Skip to content

Novel Training Environment to Normalize Altered Finger Force Direction Post Stroke

Novel Training Environment to Normalize Altered Finger Force Direction Post Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03995069
Acronym
NEAD
Enrollment
51
Registered
2019-06-21
Start date
2020-10-28
Completion date
2024-01-26
Last updated
2025-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Hand Strength, Electromyography

Brief summary

Despite the functional importance, fingertip forces are rarely explicitly addressed with feedback in therapy. This gap in treatment is due to a lack of tools to provide explicit feedback on patients' volitional finger force generation. To address this unmet need, the investigators developed a novel tool for practice of volitional three-dimensional (3D) force generation with explicit feedback. The objective of this project is to determine if 3D finger force training is an effective tool in restoring hand function post stroke.

Detailed description

Despite the functional importance, fingertip forces are rarely explicitly addressed with feedback in therapy. This gap in treatment is due to a lack of tools to provide explicit feedback on patients' volitional finger force generation. To address this unmet need, the investigators developed a novel tool for practice of volitional three-dimensional (3D) force generation with explicit feedback. The objective of this project is to determine if 3D finger force training is an effective tool in restoring hand function post stroke. Stroke survivors with moderate to severe hand impairment with at least palpable volitional grip force will randomly be assigned to either the experimental or control group, stratified by impairment level. Both groups will undergo 3 1-hr training sessions per week for 6 weeks in which they practice volitional finger force generation against force sensors. The experimental group will practice for various target force directions to explore the 3D force workspace and receive feedback in 3D force, while the control group will practice 1D force generation without feedback on other directional forces on a computer screen. Training will progress by increasing influence of flexion synergy by varying posture requirements and increasing force level, introducing feedback delay, and incorporating unilateral/bilateral activity. Evaluation will occur at baseline (3 times over 3 weeks to establish baseline trends) and every 2 weeks during 6-week intervention to determine pattern of progress, and at 1-month follow-up to assess retention.

Interventions

BEHAVIORAL3D

Practice generating grip force to the target shown on the computer screen in 3 dimensions.

BEHAVIORAL1D

Practice generating grip force to the target shown on the computer screen in 1 dimension.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Survived a stroke at least 3 months ago * Moderate to severe hand impairment (Chedoke-McMaster Hand Stage 2-4) * Ability to generate palpable volitional grip force upon cue * Sufficient cognitive ability to participate (NIH Stroke Scale, NIHSS, Questions and Commands score = 0-1) * Ability to recognize all quadrants of the visual field (NIHSS Visual Field Test score = 0)

Exclusion criteria

* Concurrent upper limb rehabilitation * Inability to follow 2-step commands * Severe muscle tone prohibiting passive movement of the fingers or proper placement of the fingers on the force sensors as needed to participate in the training (Modified Ashworth Scale=4-5 out of 5) * Change in spasticity medication or botulinum toxin injection in the upper limb within 3 months prior to or during enrollment * Total sensory loss on fingertips (NIHSS Sensory score=2) * Comorbidity (e.g., orthopaedic conditions that limit ranges of motion, premorbid neurologic conditions) * Language barrier or cognitive impairment that precludes providing consent

Design outcomes

Primary

MeasureTime frameDescription
Action Research Arm Test (ARAT)baseline to within 1 week post interventionchange in a clinical assessment, ARAT, that is in a scale 0-57 with a higher score representing better upper extremity function

Other

MeasureTime frameDescription
Box and Block Testbaseline to within 1 week post interventiona clinical assessment measuring the number of blocks that a person can move in a minute, with a higher score representing better upper extremity function
Stroke Impact Scale Hand Subscalebaseline to within 1 week post interventionPerceived difficulty in using the affected hand for activities of daily living. Scale 0-100. A higher score represents better function (less difficulty).
Action Research Arm Testbaseline to 1 month post interventionchange in a clinical assessment of Action Research Arm Test that is in a scale 0-57 with a higher score representing better upper extremity function

Countries

United States

Participant flow

Pre-assignment details

Not meeting inclusion criteria (n=1) Declined to participate (n=3) Funding ended (n=2)

Participants by arm

ArmCount
Visual Feedback of 3D Digit Force
The participant's voluntary grip forces in all 3 dimensions will be shown to the participant via computer screen. 3D: Practice generating grip force to the target shown on the computer screen in 3 dimensions.
22
Visual Feedback of 1D Digit Force
The participant's voluntary grip force in 1 dimension will be shown to the participant via computer screen. 1D: Practice generating grip force to the target shown on the computer screen in 1 dimension.
23
Total45

Baseline characteristics

CharacteristicVisual Feedback of 3D Digit ForceVisual Feedback of 1D Digit ForceTotal
Age, Continuous59 years
STANDARD_DEVIATION 12
60 years
STANDARD_DEVIATION 9
59 years
STANDARD_DEVIATION 10
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
10 Participants8 Participants18 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
12 Participants15 Participants27 Participants
Region of Enrollment
United States
22 Participants23 Participants45 Participants
Sex: Female, Male
Female
9 Participants9 Participants18 Participants
Sex: Female, Male
Male
13 Participants14 Participants27 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 220 / 23
other
Total, other adverse events
18 / 2218 / 23
serious
Total, serious adverse events
2 / 223 / 23

Outcome results

Primary

Action Research Arm Test (ARAT)

change in a clinical assessment, ARAT, that is in a scale 0-57 with a higher score representing better upper extremity function

Time frame: baseline to within 1 week post intervention

ArmMeasureValue (MEAN)Dispersion
Visual Feedback of 3D Digit ForceAction Research Arm Test (ARAT)3.5 score on a scaleStandard Error 0.65
Visual Feedback of 1D Digit ForceAction Research Arm Test (ARAT)0.8 score on a scaleStandard Error 0.66
Other Pre-specified

Action Research Arm Test

change in a clinical assessment of Action Research Arm Test that is in a scale 0-57 with a higher score representing better upper extremity function

Time frame: baseline to 1 month post intervention

ArmMeasureValue (MEAN)Dispersion
Visual Feedback of 3D Digit ForceAction Research Arm Test3.9 score on a scaleStandard Error 0.7
Visual Feedback of 1D Digit ForceAction Research Arm Test0.7 score on a scaleStandard Error 0.7
Other Pre-specified

Box and Block Test

a clinical assessment measuring the number of blocks that a person can move in a minute, with a higher score representing better upper extremity function

Time frame: baseline to within 1 week post intervention

ArmMeasureValue (MEAN)Dispersion
Visual Feedback of 3D Digit ForceBox and Block Test3.03 blocks moved in 1 minStandard Error 0.97
Visual Feedback of 1D Digit ForceBox and Block Test0.92 blocks moved in 1 minStandard Error 0.95
Other Pre-specified

Box and Block Test

a clinical assessment for upper extremity function.

Time frame: baseline to 1 month post intervention

ArmMeasureValue (MEAN)Dispersion
Visual Feedback of 3D Digit ForceBox and Block Test2.5 blocks moved in 1 minStandard Error 1
Visual Feedback of 1D Digit ForceBox and Block Test0.5 blocks moved in 1 minStandard Error 1
Other Pre-specified

Stroke Impact Scale Hand Subscale

Perceived difficulty in using the affected hand for activities of daily living. Scale 0-100. A higher score represents better function (less difficulty).

Time frame: baseline to within 1 week post intervention

ArmMeasureValue (MEAN)Dispersion
Visual Feedback of 3D Digit ForceStroke Impact Scale Hand Subscale12 score on a scaleStandard Error 2
Visual Feedback of 1D Digit ForceStroke Impact Scale Hand Subscale6 score on a scaleStandard Error 2
Other Pre-specified

Stroke Impact Scale Hand Subscale

Perceived difficulty in using the affected hand for activities of daily living. Scale 0-100. A higher score represents better function (less difficulty).

Time frame: baseline to 1 month post intervention

ArmMeasureValue (MEAN)Dispersion
Visual Feedback of 3D Digit ForceStroke Impact Scale Hand Subscale15 score on a scaleStandard Error 2
Visual Feedback of 1D Digit ForceStroke Impact Scale Hand Subscale8 score on a scaleStandard Error 2

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026